This study investigates pancreatic cancer. It seeks to discover biomarkers that can help in diagnosing, predicting, and understanding the progression of this condition.
The purpose of this study is to evaluate the effectiveness of using specific biomarkers for early detection and to improve prognostication and treatment monitoring. These biomarkers include various molecules like DNA, RNA, and proteins.
- Who can participate: Adults over 18 years old with confirmed pancreatic cancer or ampullary adenocarcinoma can participate.
- Study details: Participants will provide blood samples at various stages of their treatment.